Dr. Scott D. Patterson

• 
  www.chicorporate.com/BiomarkerSymposia_Content.aspx?id= - [Cached Version]
  Published on: 5/13/2009    Last Visited: 5/16/2009  

  Scott D. Patterson, Ph.D., Executive Director, Medical Sciences, Amgen, Inc.
  ...
  Scott D. Patterson, Ph.D., Executive Director, Medical Sciences, Amgen, Inc. Dr. Patterson returned to Amgen Inc., California in 2003 and is an Executive Director in the Medical Sciences function leading the Molecular Sciences department (with the Computational Biology department also reporting to him). Medical Sciences is responsible for conducting first-in-human studies through to Phase 2a for all therapeutic areas in the company, and Molecular Sciences is part of this function to enable biochemical determination of whether the targeted pathway is being interdicted, whether exposure:response relationships can be generated (to inform dose ranging), and in which patient populations the therapeutic may be more efficacious (should that be necessary). He is well known in the field of protein chemistry, and a pioneer in the field of proteomics. He has published extensively and is a frequent guest lecturer. After leaving Amgen in 2000, he served as Vice President of Proteomics at the Celera Genomics Group and then as Chief Scientific Officer of Farmal Biomedicines, LLC. While at Celera, he established the company's initial foray into protein-based drug target discovery and validation in oncology, building a large group of cell biologists, protein chemists and mass spectrometrists whose efforts resulted in the identification of cell surface targets for therapeutic development and diagnostics, a number of which have been licensed to Pharma and Biotechnology companies. Dr. Patterson first worked at Amgen from 1993â€"2000 progressing from a Research Scientist to Department Head, ultimately leading the Department of Biochemistry and Genetics.

• 
  www.ibclifesciences.com/D8176/speakers2.xml - [Cached Version]
  Published on: 4/18/2008    Last Visited: 4/28/2008  

  Scott Patterson, Ph.D., Executive Director.Medical Sciences, Amgen Inc.

• 
  www.cutimes.com/Issues/2009/August%2012%202009/Pages/Du - [Cached Version]
  Published on: 1/1/2009    Last Visited: 8/11/2009  

  "We're ecstatic that BECU and Suncoast Schools have made the decision to offer private student loans through Student Choice network," said Scott Patterson, executive vice president of CU Student Choice.
  ...
  "We're ecstatic that BECU and Suncoast Schools have made the decision to offer private student loans through Student Choice network," said Scott Patterson, executive vice president of CU Student Choice.

• 
  www.lifesciencesinfo.com/cod/speakers_lower.asp?pid=USC - [Cached Version]
  Published on: 2/20/2006    Last Visited: 2/20/2006  

  Scott Patterson, Ph.D., Director, Early Development, Amgen, Inc.

• 
  www.infoshop-japan.com/conference/biomarker/distinguish - [Cached Version]
  Published on: 6/14/2008    Last Visited: 6/14/2008  

  Scott D. Patterson, Ph.D., Executive Director, Medical Sciences, Amgen Inc.

• 
  www.syncmlworld.com/cod/display_lower.asp?COMPANY=UKC&P - [Cached Version]
  Published on: 11/7/2001    Last Visited: 8/5/2002  

  Dr Scott Patterson,Amgen Inc.

• 
  www.masshightech.com/stories/2008/08/04/weekly9-Old-BWH - [Cached Version]
  Published on: 8/8/2008    Last Visited: 8/11/2008  

  "This is already helping us in programs that are in early phases of the clinic, where they allow us to understand whether polymorphisms exist that could be affecting outcomes in disease progression," said Scott Patterson, Amgen's executive director of medical sciences.

• 
  www.healthnetworkcommunications.com/2008/explorusa/spea - [Cached Version]
  Published on: 1/1/2008    Last Visited: 6/26/2008  

  speakers | Professor, Sir Colin Dollery | Dr Alan Hollister | Dr Seth Berry | Dr Thorir Bjornsson | Dr Frank Weber | Dr Jorg Taubel | Dr Philip Sager | Dr Charles Beasley | Dr Anna Georgieva | Dr John Monroe | Dr Hong Wan | Dr Patricia Cole | Dr Rajesh Krishna | Dr Hui Kimko | Dr Mohammad Tabrizi | Professor Colin Garner | Dr Gert Ulrich Kuerzel | Dr Andrew Rankin | Dr Scott Patterson | Dr Edwin Clark
  ...
  Dr Scott Patterson,Executive Director Medical Science,Amgen IncDr. Patterson returned to Amgen Inc., California in 2003 and is an Executive Director in the Medical Sciences function leading the Molecular Sciences department (with the Computational Biology department also reporting into him).Medical Sciences is responsible for conducting first-in-human studies through to Phase 2a for all therapeutic areas in the company, and Molecular Sciences is part of this function to enable biochemical determination of whether the targeted pathway is being interdicted, whether exposure:response relationships can be generated (to inform dose ranging), and in which patient populations the therapeutic may be more efficacious (should that be necessary).He is well known in the field of protein chemistry, and is one of the pioneers in the field of proteomics.He has published extensively and is a frequent guest lecturer.After leaving Amgen in 2000, he served as Vice President of Proteomics at the Celera Genomics Group and then as Chief Scientific Officer of Farmal Biomedicines, LLC.
  ...
  Dr Scott PattersonExecutive Director for Medical ScienceAmgen

• 
  www.hum-molgen.org/meetings/meetings/3756.html - [Cached Version]
  Published on: 1/16/2009    Last Visited: 2/9/2009  

  XiaoHu Gao of University of Washington, Scott Patterson of Amgen Inc., Gary Geiss of Nanostring, Inc.and several biotech and pharmaceutical Communities will be speaking on the biology of stem cells and their utilizations in cell propagation transplantation and therapeutic development.

• 
  www.gotsummit.com/07-spp.asp - [Cached Version]
  Published on: 11/8/2006    Last Visited: 7/18/2007  

  Scott D. Patterson, Ph.D., Senior Director, Medical Sciences, Amgen Inc.
  ...
  Host: Scott D. Patterson, Ph.D., Senior Director, Medical Sciences, Amgen Inc.

Page:  1 2 3 4 5